This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: University of Florida Research Foundation Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Mark B. Sherwood: Innovator in Glaucoma Treatment
Introduction
Mark B. Sherwood is a notable inventor based in Gainesville, FL (US), recognized for his contributions to medical technology, particularly in the field of ophthalmology. With a total of 2 patents, he has made significant strides in developing innovative solutions for glaucoma treatment.
Latest Patents
Sherwood's latest patents include a glaucoma drainage implant venting assembly. This assembly features a drainage implant tube that defines a fluid channel between the anterior chamber of the eye and a region outside the sclera. It includes a closure designed to prevent fluid flow from the anterior chamber to the outside region, along with a shunt that allows fluid to flow from the anterior chamber through the drainage implant tube. His second patent involves intraocular pressure sensing materials, devices, and their uses. This invention describes eye implants that change color in response to pressure, providing a method for monitoring intraocular pressure in both human and animal subjects.
Career Highlights
Mark B. Sherwood is affiliated with the University of Florida Research Foundation, Incorporated, where he continues to advance his research and innovations in eye care technology. His work has the potential to significantly improve the quality of life for individuals suffering from glaucoma.
Collaborations
Sherwood collaborates with esteemed colleagues such as Craig Allen Meyers and Peng Jiang, contributing to a dynamic research environment focused on innovative medical solutions.
Conclusion
Mark B. Sherwood's contributions to glaucoma treatment through his patents and research at the University of Florida Research Foundation highlight his commitment to improving patient care. His innovative approaches are paving the way for advancements in ophthalmic technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
